Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
spacer
 MEPS Home
 About MEPS
 :: Survey Background
 :: Workshops & Events
 :: Data Release Schedule
 Survey Components
 :: Household
 :: Insurance/Employer
 :: Medical Provider
 :: Survey Questionnaires
 Data and Statistics
 :: Data Overview
 :: MEPS Topics
 :: Publications Search
 :: MEPS Data Tools (HC/IC)
 :: Data Files
 :: Data Centers
 Communication
 :: What's New
 :: Mailing List
 :: Discussion Forum
 :: Participants' Corner
   
MEPS Topics: Priority Conditions -- General
Click here for full topic list.

Visit the AHRQ Data Tools to explore AHRQ data resources to view and analyze statistics on all aspects of healthcare in the United States.

""
Priority Conditions -- General
Description: The Priority Conditions section of the MEPS-HC questionnaire, added in 2000 (Panel 4 Round 5 and Panel 5 Round 3), collects information about a select group of medical conditions including sore or strep throat, diabetes, asthma, hypertension, coronary heart disease, angina, heart attacks, other heart disorders, strokes, emphysema, joint pain, and arthritis. MEPS collects information about a select group of medical conditions that have been specified by the Agency for HealthCare Research and Quality as "priority conditions." These conditions, selected for their prevalence, expense, or relevance to policy, are: hypertension, heart disease, high cholesterol, emphysema, chronic bronchitis, diabetes, cancer, arthritis, asthma, attention deficit/hyperactivity disorder (ADHD or ADD), and stroke. In addition to the tables and publications below, person-level data files with priority condition variables can be downloaded for analysis.
Publications: Publications are listed in reverse chronological order (most recent first).
Average Annual Health Care Use and Expenditures for Kidney Disease among Adults 18 and Older, U.S. Civilian Noninstitutionalized Population, 2003-2007 
Statistical Brief #306 
Trends in the Pharmaceutical Treatment of Diabetes, 1997 to 2007 
Research Findings #30 
Trends in the Pharmaceutical Treatment of Diabetes: A Comparison of Utilization and Expenditures, 1997 to 2007 
Statistical Brief #293 
Trends in Select Reported Chronic Conditions for Persons under Age 40 in the U.S. Civilian Noninstitutionalized Population, 1997 and 2007 
Statistical Brief #292 
Back Problems: Use and Expenditures for the U.S. Adult Population, 2007 
Statistical Brief #289 
The Five Most Costly Conditions, 1996 and 2006: Estimates for the U.S. Civilian Noninstitutionalized Population 
Statistical Brief #248 
The Five Most Costly Children's Conditions, 2006: Estimates for the U.S. Civilian Noninstitutionalized Children, Ages 0-17 
Statistical Brief #242 
Total Medical and Prescription Expenditures by Current Asthma Status and Whether Asthma Daily Preventive Medicine Is Being Taken, United States, 2006 
Statistical Brief #241 
Choice of Angiotensin Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers among Hypertensive Adults: Nationally Representative Estimates, 1997-2004 
Working Paper #9001 
Health Insurance Coverage of Near Elderly Individuals, Ages 55-64, 2006 
Statistical Brief #239 
Asthma Preventive Medicine in 2006 - Who Takes Them? 
Statistical Brief #237 
The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2006 
Statistical Brief #232 
Arthritis: Use and Expenditures among U.S. Adult Noninstitutionalized Population, 2005 
Statistical Brief #222 
The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for the Medicare Population Age 65 and Older in the U.S. Civilian Noninstitutionalized Population, 2005 
Statistical Brief #199 
The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2005 
Statistical Brief #198 
Estimating the Cost of Illness: The Case of Diabetes 
Working Paper #8001 
Aspirin Use among the Adult U.S. Noninstitutionalized Population, with and without Indicators of Heart Disease, 2005 
Statistical Brief #179 
Asthma Treatment and Management among the U.S. Civilian Noninstitutionalized Population, 2004 
Statistical Brief #152 
Proportion and Medical Expenditures of Adults Being Treated for Diabetes, 1996 and 2003 
Statistical Brief #146 
Persistence in Medicare Prescription Drug Expenditures by Treatment Class 
Working Paper #6006 
<<Prev<<   21 to 40 of 54   >>Next>>
 
   Page last revised:  January 27, 2023
MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov